Review Articles Covering T Cell Receptors and Clinical Trials for B Cell Malignancies
For additional information about T Cell Receptors and the results of early clinical trials in B cell malignancies, see the following review articles.
Advancing Cancer Therapy with Present and Emerging Immuno-Oncology Approaches. Front Oncol. 2017;7:64.
Antigen receptor-redirected T cells derived from hematopoietic precursor cells lack expression of the endogenous TCR/CD3 receptor and exhibit specific antitumor capacities. Oncoimmunology. 2017;6(3):e1283460.